
Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.

Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.

Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.

February 24th 2016

April 20th 2016